Research progress of Ustekinumab in the treatment of inflammatory bowel disease

Overview of attention for article published in Frontiers in immunology, February 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Readers on

mendeley: 3 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 33,568 followers.

RT @FrontImmunol: New Research: Research progress of Ustekinumab in the treatment of inflammatory bowel disease: Inflammatory bowel disease…

22 Feb 2024

Reply Repost Favourite

RT @FrontImmunol: New Research: Research progress of Ustekinumab in the treatment of inflammatory bowel disease: Inflammatory bowel disease…

22 Feb 2024

Reply Repost Favourite

New Research: Research progress of Ustekinumab in the treatment of inflammatory bowel disease: Inflammatory bowel disease (IBD) is a chronic, recurrent gastrointestinal disorder with elusive etiology. Interleukin-12 (IL-12) and IL-23 have… https://t.co/Nb0

22 Feb 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.